248921-61-1

Basic information

• Product Name: (S)-Azepane-1-carboxylic acid [1-(3,3-diphenyl-propylcarbamoyl)-3-methyl-butyl]-amide
• Synonyms: (S)-Azepane-1-carboxylic acid [1-(3,3-diphenyl-propylcarbamoyl)-3-methyl-butyl]-amide
• CAS NO: 248921-61-1
• Molecular Weight: 449.637
• Mol File: 248921-61-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-Azepane-1-carboxylic acid [1-(3,3-diphenyl-propylcarbamoyl)-3-methyl-butyl]-amide(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-Azepane-1-carboxylic acid [1-(3,3-diphenyl-propylcarbamoyl)-3-methyl-butyl]-amide(248921-61-1)
• EPA Substance Registry System: (S)-Azepane-1-carboxylic acid [1-(3,3-diphenyl-propylcarbamoyl)-3-methyl-butyl]-amide(248921-61-1)

Safety Data

• Hazardous Substances Data: 248921-61-1(Hazardous Substances Data)

Upstream product

• 141595-75-7 (S)-2-[(azepane-1-carbonyl)-amino]-4-methyl-pentanoic acid benzyl ester 
• 1738-69-8 L-Leucine benzyl ester 
• 111-49-9 hexamethylene imine 
• 5586-73-2 3-diphenylpropyl amine 
• 94790-37-1 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 
• 141595-76-8 (S)-2-[(Azepane-1-carbonyl)-amino]-4-methyl-pentanoic acid 

Relevant articles and documents

Substituted diarylalkyl amides as calcium channel antagonists

The present invention provides compounds that block calcium channels and have the Formula I: The present invention also provides pharmaceutical compositions containing the compounds of Formula I and methods of using them to treat stroke, cerebral ischemia